Aditya Tedjaseputra

Clayton, QLD, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analyses.

Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analyses.

Journal: Blood advances
Published: February 05, 2026

Historical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses.

Historical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses.

Journal: Blood advances
Published: February 05, 2026

SOHO State of the Art Updates and Next Questions: Is Favorable-risk AML Always Favorable?

SOHO State of the Art Updates and Next Questions: Is Favorable-risk AML Always Favorable?

Journal: Clinical lymphoma, myeloma & leukemia
Published: January 23, 2026

Safety and efficacy of combining midostaurin and gemtuzumab ozogamicin with induction chemotherapy in FLT3-mutated AML.

Safety and efficacy of combining midostaurin and gemtuzumab ozogamicin with induction chemotherapy in FLT3-mutated AML.

Journal: Blood advances
Published: May 23, 2025

Dynamic Profiling of Cell Free Tumour DNA in Aggressive B-Cell Lymphoma From Diagnosis to Transformation at Relapse.

Dynamic Profiling of Cell Free Tumour DNA in Aggressive B-Cell Lymphoma From Diagnosis to Transformation at Relapse.

Journal: EJHaem
Published: March 24, 2025

Ratifying the efficacy and safety of intensive induction chemotherapy for acute myeloid leukaemia by the Australasian Leukaemia & Lymphoma Group consensus approach.

Ratifying the efficacy and safety of intensive induction chemotherapy for acute myeloid leukaemia by the Australasian Leukaemia & Lymphoma Group consensus approach.

Journal: Internal medicine journal
Published: August 22, 2024

Pain crisis complicating severe bone marrow necrosis during induction for acute promyelocytic leukaemia.

Pain crisis complicating severe bone marrow necrosis during induction for acute promyelocytic leukaemia.

Journal: Pathology
Published: May 13, 2024

SOHO State of the Art Updates and Next Questions: Pre-emptive Therapy at Molecular Measurable Residual Disease Failure in Acute Myeloid Leukemia.

SOHO State of the Art Updates and Next Questions: Pre-emptive Therapy at Molecular Measurable Residual Disease Failure in Acute Myeloid Leukemia.

Journal: Clinical lymphoma, myeloma & leukemia
Published: March 01, 2024

Day-21 bone marrow findings incorrectly designate residual leukaemia in FLT3-mutated acute myeloid leukaemia treated with intensive induction plus midostaurin: a morphology-focused study.

Day-21 bone marrow findings incorrectly designate residual leukaemia in FLT3-mutated acute myeloid leukaemia treated with intensive induction plus midostaurin: a morphology-focused study.

Journal: Pathology
Published: October 10, 2023

Candida parapsilosis bone marrow infection in an immunocompetent patient.

Candida parapsilosis bone marrow infection in an immunocompetent patient.

Journal: IDCases
Published: October 05, 2023

Pearson syndrome.

Pearson syndrome.

Journal: American journal of hematology
Published: November 11, 2022

Characteristics and outcomes of patients with acute promyelocytic leukemia and extreme hyperleukocytosis at presentation.

Characteristics and outcomes of patients with acute promyelocytic leukemia and extreme hyperleukocytosis at presentation.

Journal: Blood advances
Published: July 18, 2022
Showing 1-12 of 20

Last Updated: 09/26/2026